Narrow search
Showing 1 - 4 of 4
Cover Image
Who gets medication-assisted treatment for opioid use disorder, and does it reduce overdose risk? : evidence from the Rhode Island all-payer claims database
Burke, Mary A.; Sullivan, Riley; Carman, Katherine Grace; … - 2021 - This version: February 2021
Medication-assisted treatment (MAT) for opioid use disorder (OUD) consists of administering methadone, buprenorphine, or naltrexone in conjunction with behavioral therapy. Despite strong support in the medical and public health communities for MAT, fewer than 10 percent of US patients with...
Persistent link: https://www.econbiz.de/10012486759
Cover Image
Did the affordable care act affect access to medications for opioid use disorder among the already insured? : evidence from the Rhode Island all-payer claims database
Burke, Mary A.; Carman, Katherine Grace; Sullivan, Riley; … - 2021 - This version: October 2021
Previous research suggests that state Medicaid expansions implemented under the Patient Protection and Affordable Care Act (ACA) helped large numbers of patients suffering from opioid use disorder (OUD) gain access to life-saving medications, including buprenorphine. However, Medicaid expansions...
Persistent link: https://www.econbiz.de/10012796257
Cover Image
Did the affordable care act affect access to medications for opioid use disorder among the already insured? Evidence from the Rhode Island all-payer claims database
Burke, Mary A.; Carman, Katherine Grace; Sullivan, Riley; … - 2021
Previous research suggests that state Medicaid expansions implemented under the Patient Protection and Affordable Care Act (ACA) helped large numbers of patients suffering from opioid use disorder (OUD) gain access to life-saving medications, including buprenorphine. However, Medicaid expansions...
Persistent link: https://www.econbiz.de/10012882649
Cover Image
Who gets medication-assisted treatment for opioid use disorder, and does it reduce overdose risk? Evidence from the Rhode Island all-payer claims database
Burke, Mary A.; Sullivan, Riley; Carman, Katherine Grace; … - 2021
Medication-assisted treatment (MAT) for opioid use disorder (OUD) consists of administering methadone, buprenorphine, or naltrexone in conjunction with behavioral therapy. Despite strong support in the medical and public health communities for MAT, fewer than 10 percent of US patients with...
Persistent link: https://www.econbiz.de/10012606362